Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03076008 · ClinicalTrials.gov registry record
The Impact of Tibial Tubercle-trochlear Groove Distance and Patellar Height on the Outcome of Isolated Medial Patellofemoral Ligament Reconstruction
A clinical trial of Patellar Dislocation, sponsored by University of Minnesota.
- Active
- Registry status
- 201
- Enrollment target
- 1
- Study location
NCT03076008: Active study of Patellar Dislocation, sponsored by University of Minnesota.
NCT03076008 is a study of Patellar Dislocation that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 201 participants, below the 329-participant average among 3 other Patellar Dislocation trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03076008, a study of Patellar Dislocation, is active but no longer recruiting, sponsored by University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- 201 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators plan to perform a prospective observational cohort study of patients undergoing MPFL reconstruction for the treatment of episodic patellar instability in the absence of significant degenerative disease. The investigators will follow these study subjects for a minimum of two years to monitor their functional and clinical outcome.
Primary Outcome
Recurrent Dislocation
Conditions Studied
Interventions
- OTHER Observational
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2016-10-01 |
| Est. Completion | 2026-06-30 |
What the registry record for NCT03076008 still lists
NCT03076008 is an observational study that tracks outcomes without assigning an intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 329-participant average among 3 other Patellar Dislocation trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Patellar Dislocation appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT03076008 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03076008 about?
NCT03076008 is a clinical study titled "The Impact of Tibial Tubercle-trochlear Groove Distance and Patellar Height on the Outcome of Isolated Medial Patellofemoral Ligament Reconstruction". The investigators plan to perform a prospective observational cohort study of patients undergoing MPFL reconstruction for the treatment of episodic patellar instability in the absence of significant degenerative disease. The investigators will follow these study subjects for a minimum of two years t...
What is the current status of trial NCT03076008?
This trial is currently active not recruiting. The enrollment target is 201 participants. The study started on 2016-10-01. Estimated completion is 2026-06-30.
What conditions does trial NCT03076008 study?
This clinical trial studies the following conditions: Patellar Dislocation.
What interventions are being tested in trial NCT03076008?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT03076008?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03076008 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patellar Dislocation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI